SIGA TECHNOLOGIES INC. - COMMON STOCK

SIGA Technologies CEO to Speak at NCT USA Conference September 8, 2021

07 Sep 2021 13:16:50 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021

05 Aug 2021 16:15:00 By Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on August 5th, 2021 Following Release of Second Quarter 2021 Financial Results

29 Jul 2021 16:15:00 By Nasdaq GlobeNewswire

SIGA Announces Collaboration with Oxford University to Support Expanded Access Protocol for Use of TPOXX® (Tecovirimat) To Treat Monkeypox in Central African Republic

29 Jul 2021 03:30:00 By Nasdaq GlobeNewswire

SIGA Supplies TPOXX® (Tecovirimat) as Compassionate Treatment for Monkeypox Case in the United Kingdom

30 Jun 2021 07:30:00 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three Months Ended March 31, 2021

06 May 2021 16:05:01 By Nasdaq GlobeNewswire

SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX

04 May 2021 07:30:00 By Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on May 6th, 2021 Following Release of First Quarter 2021 Financial Results

29 Apr 2021 08:00:01 By Nasdaq GlobeNewswire

Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats

23 Mar 2021 08:00:01 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2020

04 Mar 2021 16:05:01 By Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on March 4, 2021 Following Release of Year End 2020 Financial Results

26 Feb 2021 07:30:00 By Nasdaq GlobeNewswire

SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX®

13 Jan 2021 16:45:00 By Nasdaq GlobeNewswire